Search 

Exhibiting at booth 6 with the UK delegation

BioPartner UK leads the UK Delegation to several partnering conferences
each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.

BioPartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and
in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets.

Clinical Network Services (CNS) is an integrated service group focused on product development headquartered in Australia with offices in New Zealand, the UK, the Netherlands and the USA. CNS creates value for small-medium sized biotechnology companies by progressing early stage products through phase 1 & 2 clinical trials or the marketplace sooner. CNS offers a unique service where it integrates BioDesk, an intelligent global product development and regulatory affairs consultancy, with our committed, highly experienced Australian/New Zealand clinical operations and biometrics team. BioDesk’s expert consultants offer CMC/manufacturing, toxicology, clinical and regulatory affairs strategic advice and guide products efficiently through critical post-discovery development and into the clinic for the first time. With over 20 years’ experience on more than 950 projects, CNS is one of the most experienced providers within the market and a partner of choice for biotech companies. CNS’s small-medium size is considered a big advantage when relating to similar sized clients, though CNS takes a global development/ regulatory approach to ensure value is strategically added at every stage of the product development life cycle.

At Karma Oncology we are committed to helping our clients advance their oncology programs to the next stage. 

Pioneering early stage companies leverage our experienced panel of clinical development experts to develop best-in-class Clinical Development Plans to attract the right investors and optimise the clinical and regulatory strategy. 

Clinical stage companies come to us for our operational excellence and then stay with us for our industry leading quality and low-overhead pricing. We understand that experience, speed and excellent site relationships are the key to effective clinical study delivery.  And with Karma, you get the same team from start-to-finish, not only because we have among the lowest staff turnover in the business (<5% annually), but because we do not have a start up team and a monitoring team, it is all one team delivered by our career CRAs who provide continuity and expertise.

Our expertise is in solid tumours and haematological malignancies and spans a multitude of therapeutic approaches including autologous and CAR-T cell therapies. While oncology is in our name, we do also have experience in many other indications and our sister company, Karma Cardiology provides the same services for cardiology and cardiovascular disease.

The Life Science Network for Wales

Founded in 1992, MediWales is the life science network and representative body for Wales. MediWales provides advice, support and business opportunities for our members, whilst promoting collaboration within the life science and health technology community in Wales.

With 180 members, our network is largely made up of life science organisations, pharmaceutical services and medical technology companies. We actively encourage engagement with the clinical research community and our membership includes NHS health boards and universities. We are an independent, not-for-profit limited company.

Our mission is ‘The advancement of human life science in Wales.’ 

Our focus is creating opportunities for our members.

Exhibitng at booth 9

The National Institute for Health Research (NIHR) is unique, it is the worlds most integrated research network and provides a gateway for you to carry out your clinical research and technology evaluation in the NHS.  
We are a government funded organisation, founded in 2006 to improve the health and wealth of the nation, we work with a diverse range of industry sectors, including diagnostics, medical technology, biopharmaceutical and CROs, as well as with associated industries such as digital, design and artificial intelligence.  We offer a free of charge, robust feasibility service to all companies that have eligible study proposals. This includes an expert protocol/synopsis review, providing national level feasibility of the ""doability"" and compatibility of the trial in the NHS. Along with 2 site level feasibility services, 1 of which identifies potential centers to run your trial, all done within 3 weeks. We also provide support through the set up and recruitment phase to ensure your study is set up swiftly and delivers the target number of patients on time.  We have helped demonstrate that the UK is globally competitive in speed of study set up by recruiting 28 global firsts into commercial trials last year. We also supported the recruitment of over 870,000 participants onto clinical trials in the last financial year.  We have worked with and provided support to over 1300 different companies over the years.

Pebmond Associates provides multifaceted board-level advisory, business development and licensing services. Operating in the EU, US and emerging markets we add value to clients by providing solutions for developing and growing pharma companies, including services from a network of trusted partner companies.

The BioIndustry Association (BIA) is the national trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. Our members include: Start-ups, biotechnology and innovative life science companies, Pharmaceutical and technological companies, Universities, research centres, tech transfer offices, incubators and accelerators. A wide range of life science service providers: investors, lawyers, IP consultants, IR agencies. We promote an ecosystem that enables innovative life science companies to start and grow successfully and sustainably, and we do this through Influence, Connect, Save:

Influence
The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators, to patient groups and the media. We also work with organisations at an international level to ensure that UK biotech is represented on the global stage including Europabio, EFPIA and ICBA.  BIA is the key thought leader for the sector – working across a wide range of related issues including policy, finance, science, regulatory, legal and talent.

Connect
The BIA provides many varied opportunities for life science leaders to connect with each other – to network, share and learn from experience, to access sector thought leadership and to take key issues forward.  From the famed BIA Gala Dinner, to the CEO &amp; Investor Forum, Women in Biotech networking evenings, quarterly committee meetings and our many regional events, to name but a few, the BIA provides access to a highly respected and diverse network. BIA also works to ensure that we provide opportunities and promotion for our members internationally – through panels and networking events at major events overseas, we are raising the profile of the UK as a global hub.  We know that promoting what you do as an organisation is important, and we help organisations to raise their profile – at events and through our online presence and communications.

Save
For many of our emerging members (and a good number of well-established ones too) the BIA Business Solutions Scheme provides significant savings that are helping them to grow more cost-effectively.  We believe this is the most competitive scheme of its kind in the UK.